NCT00104130View on ClinicalTrials.gov

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2005

Conditions
Prostate Cancer
Interventions
DRUG

KOS-862

Trial Locations (9)

19111

Fox Chase Cancer Center, Philadelphia

21201

University of Maryland Medical System, Baltimore

30084

Georgia Cancer Specialists, Tucker

44195

The Cleveland Clinic Foundation, Cleveland

63310

Washington University School of Medicine, St Louis

94589

Kaiser Permanente Medical Center, Vallejo

97227

Kaiser Permanente NW Oncology Clinic, Portland

97239

Oregon Health & Science University, Portland

98109

University of Washington, Seattle

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY